Improving Infection Control: Vaasa Central Hospital Pilots UV-C Disinfection Robot

As an early adopter located near Done Robotics’ headquarters, Vaasa Central Hospital provided a real-world testing ground for Charlie, an autonomous UV-C disinfection robot originally developed during the COVID-19 pandemic. The urgency of that period highlighted a clear need: faster, more reliable disinfection methods that could operate consistently in complex hospital settings.

From Concept to Clinical Environment

Charlie was designed to navigate dynamic healthcare environments safely, detecting obstacles and operating in close proximity to staff and patients. During the pilot at Vaasa Central Hospital, the robot was primarily deployed in patient rooms—areas where effective and repeatable disinfection is critical for preventing healthcare-associated infections.

Unlike manual cleaning alone, UV-C technology enables rapid inactivation of microorganisms on surfaces exposed to the light. Charlie’s system delivers this in a controlled and automated way, reducing variability between cleaning cycles. In practice, hospitals often find that maintaining consistent disinfection quality across shifts and staff can be challenging—automation helps address this gap.

A video shared by the hospital offers a glimpse into how Charlie operates in a real clinical setting:
https://www.instagram.com/p/DI3SDsxKsXJ/

Complementing, Not Replacing, Existing Workflows

A key takeaway from the pilot is that UV-C robotics are not intended to replace manual cleaning, but to strengthen it. At Vaasa Central Hospital, Charlie was used as a preventive, complementary layer—specifically targeting residual pathogens that traditional methods may miss.

This approach aligns with how many healthcare providers evaluate new technologies: not as standalone solutions, but as enhancements to existing workflows. Decision-makers often prioritize solutions that integrate smoothly without adding complexity or requiring significant staffing changes.

In this case, Charlie’s autonomous operation meant that staff could initiate a disinfection cycle and focus on other tasks, helping optimize time and resource allocation—an ongoing challenge in many hospitals.

Validated Performance Builds Confidence

Technology adoption in healthcare depends heavily on trust and evidence. To support real-world use, Charlie’s disinfection performance has been independently tested by Novia University of Applied Sciences. These tests verified its effectiveness against multiple microorganisms, providing an additional layer of assurance for clinical use.

For many hospitals, this type of validation is a key factor in overcoming adoption barriers. While innovation is welcomed, proven efficacy and safety remain non-negotiable.

Local Collaboration Driving Practical Innovation

The collaboration between Done Robotics and Vaasa Central Hospital highlights the value of close, local partnerships in healthcare innovation. By piloting in a live hospital environment, both parties gained insights that go beyond laboratory conditions—addressing real operational challenges such as room turnover times, workflow integration, and staff interaction.

In practice, hospitals evaluating robotic solutions often look for exactly this: evidence that the technology works not just in theory, but in day-to-day operations.

Looking Ahead

The pilot at Vaasa Central Hospital demonstrates how autonomous UV-C disinfection can be implemented in a practical, scalable way. As healthcare systems continue to focus on infection prevention, staffing efficiency, and operational resilience, solutions like Charlie offer a compelling addition to the toolkit.

For decision-makers, the key question is no longer whether automation has a role in infection control—but how to implement it in a way that delivers measurable value without disrupting care delivery.